Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

Novoron Bioscience: Valuation, Funding & Investors

7770 Regents Rd #113319 San Diego, California 92122, UShttps://novoron.com/Therapeutics

Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing therapeutics for neurodegenerative diseases and neurological injury. The company focuses on human iPSC-derived cortical organoid platforms and LRP1-targeted approaches to accelerate Alzheimer’s disease and tauopathy drug discovery.

Leadership & Board

Current Number of Employees: 14
Current LinkedIn Followers: 2,612

Latest Estimated Valuation

Total Amount Raised: $3M
Total Funding Rounds: 1
Latest Funding Amount: $3M
Latest Funding Round: Investment

Company Momentum Positive

Articles Published on TipRanks1

LinkedIn Trend+0.38% followers

Workforce Trend+0.0% employees

Novoron Bioscience LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

Novoron Bioscience had 14 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

14Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Novoron Bioscience had 2,612 followers as of October 26, 2026. The number of followers increased by 10 (0.38%) week-over-week.

2,612Latest Followers Count

10(0.38%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Jan 06, 2026	Investment	$2.50M	―

Investors

Investor Name	Funding Round
National Institute on Aging at the National Institutes of Health (NIH)	Investment

Similar Companies

A snapshot of private companies similar to Novoron Bioscience, helping you discover and navigate related company profiles.

CDX Medical Technologies

Related News and Analysis

Ecosystem Support and Partnerships Bolster Novoron Bioscience’s Neurology Pipeline

Ecosystem Support and Partnerships Bolster Novoron Bioscience’s Neurology Pipeline

According to a recent LinkedIn post from Novoron Bioscience, the company is emphasizing the role that the San Diego JLABS incubator has played in its evolution since 2014. The post

1w ago

Spinal Cord Injury Therapeutics Draw Interest as Novoron Bioscience Monitors Phase 3 Developments

Spinal Cord Injury Therapeutics Draw Interest as Novoron Bioscience Monitors Phase 3 Developments

According to a recent LinkedIn post from Novoron Bioscience, the company emphasizes its strategic focus on complex neurological conditions, particularly spinal cord injury. The post references prior validation of its

2w ago

Novoron Bioscience Highlights Strategic Focus on Parkinson’s Therapeutics

Novoron Bioscience Highlights Strategic Focus on Parkinson’s Therapeutics

According to a recent LinkedIn post from Novoron Bioscience, the company aligns itself with broader efforts to advance Parkinson’s disease research and treatment. The post congratulates Michael J. Fox on

1M ago

Novoron Bioscience Emphasizes Tau-Spread Strategy in Light of New Alzheimer’s Trial Data

Novoron Bioscience Emphasizes Tau-Spread Strategy in Light of New Alzheimer’s Trial Data

A LinkedIn post from Novoron Bioscience discusses Phase 2 data Biogen presented at the Alzheimer’s Association International Conference 2026 on diranersen, an antisense therapy targeting tau. The post notes that

3M ago

Novoron Bioscience Wins $2.5 Million NIH Grant to Advance Human Organoid Platform for Alzheimer’s Drug Discovery

Novoron Bioscience Wins $2.5 Million NIH Grant to Advance Human Organoid Platform for Alzheimer’s Drug Discovery

New updates have been reported about Novoron Bioscience. Novoron Bioscience has secured a $2.5 million Small Business Innovation Research grant from the National Institute on Aging, providing non-dilutive capital to

9M ago

Collective Secures $100 Million to Scale AI-Driven Finance Platform for Solo Businesses

Collective Secures $100 Million to Scale AI-Driven Finance Platform for Solo Businesses

New updates have been reported about Collective. Collective has raised $100 million to accelerate development of its AI-native financial operating system for solo entrepreneurs as the U.S. population of Businesses-of-One

8m ago

Reducto Launches AI-Native Office Plugin for Full-Fidelity Document Editing in ChatGPT

Reducto Launches AI-Native Office Plugin for Full-Fidelity Document Editing in ChatGPT

New updates have been reported about Reducto. Reducto has launched Reducto Office, a free plugin that embeds full-fidelity editing of Word, PowerPoint and Excel files directly into AI agents such

2h ago

NewCore Wins Cyber Innovation Award for Unifying Human and AI Identity Governance

NewCore Wins Cyber Innovation Award for Unifying Human and AI Identity Governance

New updates have been reported about NewCore. NewCore has been recognized by Enterprise Security Tech’s Cyber Top Innovations Awards for its unified identity platform, underscoring the company’s role in governing

3h ago

Fever Expands Candlelight Franchise With One-Night Halloween Concert at NYC’s Vessel

Fever Expands Candlelight Franchise With One-Night Halloween Concert at NYC’s Vessel

New updates have been reported about Fever. Fever is using its Candlelight concert series to activate one of New York City’s most recognizable structures, hosting a one-night “Haunted Evening of

5h ago

Wabi Secures $55 Million, Hits $1.25 Billion Valuation to Scale Shared Personal AI Platform

Wabi Secures $55 Million, Hits $1.25 Billion Valuation to Scale Shared Personal AI Platform

New updates have been reported about Wabi. Wabi, the personal AI platform founded by Replika creator Eugenia Kuyda, has raised $55 million in new funding at a $1.25 billion valuation,

5h ago